Dental · Independent exam preparation
American Board of Periodontology Qualifying Examination: 2027 Preparation Guide Study Guide
Practise periodontal diagnosis, prognosis, treatment sequencing, implant decisions, and evidence appraisal across all 11 domains of the ABP 2027 Qualifying Examination.
By CertMedbry · Updated 30 October 2026
Build defensible decisions from periodontal measurements, progression evidence, patient risk, defect anatomy, and treatment response. These 60 selected concepts connect foundational mechanisms with diagnosis, prognosis, periodontal and implant treatment, maintenance, oral medicine, and systemic relationships. All 11 domains of the official 2027 outline are represented. The official outline defines the full examination scope; this selective guide does not replace its broader objectives in biomedical science, materials, surgical techniques, medical management, and restorative care.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination and certification stage does this guide address?
It addresses the ABP Qualifying Examination. The expanded name American Board of Periodontology Qualifying Examination identifies the same examination. The candidate guide places it before the Oral Examination in a two-part certification process. Passing the qualifying stage alone does not complete board certification.
Which blueprint applies, and when does the announced examination occur?
The announced January 25–29, 2027 administration uses the new Qualifying Exam 2027 blueprint. The issuer information was checked on October 30, 2026. The blueprint identifies its examination year but gives no separate publication date. The July 2025 date on the candidate guide's approved-journals appendix does not date the entire guide.
Qualifying Examination — American Board of Periodontology · Qualifying Exam 2027 — Domain/Objective · Candidate's Guide to Board Certification — Qualifying Exam
How many questions are scored, how many are pretest, and how long is the examination?
ABP describes a one-day examination offered during a five-day annual window, with candidates registered for five-hour seat time. Seat time is the scheduled examination appointment duration; it should not be assumed to equal five hours of timed answering. The available issuer information does not establish the total question count, scored/pretest split, or separate timed answering duration. Consult the current candidate materials and authorized appointment information for those details.
Qualifying Examination — American Board of Periodontology · Policies & Resources — American Board of Periodontology
What delivery method and item styles are verified?
The issuer describes a computer-delivered multiple-choice examination scheduled through Pearson VUE testing centers. The available information does not establish adaptive delivery or more specific operational item formats. This guide's 20 four-option, single-best-answer questions are independent learning drills.
Are official domain percentages available?
The five-page 2027 blueprint lists domains A–K and their objectives without numerical domain weights. This guide therefore uses editorial allocation: eight concepts each in foundational knowledge, diagnosis, and periodontal therapy; six each in patient management and implant therapy; and four in each remaining domain. The questions and cards also cover every domain without claiming official weighting.
Does the 2027 benchmarking announcement change result expectations?
The issuer specifically calls the 2027 administration a benchmarking examination and states that result distribution will require additional time. Its general timeline also mentions six to eight weeks, but that general statement should not be treated as a guaranteed timetable for this administration.
This guide addresses the American Board of Periodontology's Qualifying Examination, the qualifying stage preceding its Oral Examination in specialty board certification in periodontics and dental implant surgery. The questions and flashcards are independent educational materials.
Outline used: Qualifying Exam 2027 blueprint, announced for the January 25–29, 2027 administration; verified on 2026-10-12, Asia/Hong_Kong. The workbook label expands the issuer's name alongside its official examination title, Qualifying Examination. It identifies the same examination, not a separate credential. The blueprint specifies its examination year but displays no separate publication date or domain percentage weights.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
A. Foundational Knowledgenot stated
1.How does lidocaine interrupt dental pain transmission?
Lidocaine produces local anesthesia by inhibiting ionic fluxes required for initiation and conduction of nerve impulses. Its clinically important action is blockade of voltage-dependent sodium channels, preventing sufficient depolarization from propagating along the nerve. The discriminating point is interruption of conduction rather than removal of the inflammatory cause. Successful anesthesia can permit instrumentation or surgery while the underlying periodontal disease still requires diagnosis, source control, and subsequent assessment of healing.
Apply it
A patient becomes comfortable after local infiltration before periodontal surgery. Explain that the anesthetic temporarily prevents neural impulse propagation; the planned debridement and subsequent plaque control address the disease process that the anesthetic itself does not treat.
Common pitfall: Do not describe local anesthesia as an antimicrobial effect or as elimination of inflammation. Loss of pain sensation does not demonstrate successful periodontal treatment.
2.Why is epinephrine combined with a local anesthetic?
Epinephrine constricts local blood vessels, reducing the rate at which lidocaine leaves the injection site and enters systemic circulation. This can prolong useful local anesthesia and improve local hemostasis. The anesthetic and vasoconstrictor therefore perform different functions: lidocaine interrupts neural conduction, whereas epinephrine modifies local vascular uptake. Selection still requires attention to the patient's medical status and the product labeling; the presence of a vasoconstrictor does not make systemic exposure impossible.
Apply it
During surgical planning, a resident attributes longer anesthesia entirely to stronger sodium-channel blockade by epinephrine. Correct the explanation by linking epinephrine to vasoconstriction and reduced local anesthetic uptake, while retaining patient-specific medical assessment.
Common pitfall: Avoid treating epinephrine as the primary nerve-blocking drug. Reduced uptake changes the exposure profile but does not eliminate cardiovascular considerations or labeling limits.
3.Why does selective cell repopulation matter in periodontal regeneration?
Healing on a previously diseased root depends partly on which cells reach and populate the wound surface. The original human experimental work demonstrated new attachment when conditions favored periodontal ligament-derived cells. This supports the biological principle behind guided tissue regeneration: wound organization matters, rather than simply filling a defect. The experiment provides mechanistic evidence for selected conditions; it does not establish that every membrane, graft, or defect will produce the same clinical result.
Apply it
A trainee proposes judging a regenerative procedure only by whether material occupies the radiographic defect. Redirect the discussion toward the wound environment, access of appropriate cells, and evidence that the chosen procedure can support new attachment.
Common pitfall: Do not equate placement of a barrier or graft with guaranteed regeneration. A plausible cellular mechanism and a successful result are separate evidentiary claims.
New attachment following surgical treatment of human periodontal disease
4.What distinguishes histologic new attachment from clinical improvement?
Clinical attachment gain measures a change in the position reached by a periodontal probe relative to a fixed reference. Histologic new attachment requires tissue-level evidence of a newly formed attachment apparatus on a previously diseased root, including new cementum with inserting fibers. Reduced probing depth and radiographic fill can support clinical success, but neither independently identifies the microscopic healing pattern. Match the strength of the conclusion to the outcome actually measured.
Apply it
A trial reports attachment gain and radiographic defect fill after treatment but includes no histology. Describe the findings as clinical and radiographic improvement, while explaining that they do not directly demonstrate the microscopic composition of the healed attachment.
Common pitfall: Avoid upgrading a favorable surrogate measurement into histologic proof. Probing changes and radiographic appearance cannot independently distinguish every possible form of periodontal repair.
New attachment following surgical treatment of human periodontal disease
5.How are relative risk and absolute risk difference calculated?
Relative risk divides the event risk in one group by the event risk in a reference group, using the same outcome and observation period. Risk difference subtracts the reference risk from the first group's risk. A relative risk of one indicates equal observed risks. Pair the ratio with absolute risks: risks of 2% versus 1% and 20% versus 10% both give a relative risk of two, but their differences are one and ten percentage points.
Apply it
In a hypothetical cohort, 30 of 150 exposed patients and 15 of 150 unexposed patients develop the outcome. The risks are 20% and 10%, the relative risk is 2, and the risk difference is ten percentage points.
Common pitfall: Do not compare event counts without checking denominators or confuse a proportional change with a percentage-point difference. The association alone does not establish causation.
6.Which socket structures influence immediate implant placement and restoration?
The facial socket wall and the bone apical and lingual to the socket have distinct planning roles. Facial wall integrity supports the tissue envelope, while available apical and lingual bone contributes to primary fixation. The ITI immediate-placement/immediate-restoration criteria include intact socket walls, facial bone at least 1 mm thick, and sufficient apical and lingual bone for stability, alongside other clinical requirements.
Apply it
A socket has a facial wall defect despite available apical bone. Reconsider the immediate protocol and assess augmentation needs.
Common pitfall: Apical fixation does not establish that the facial tissue-support requirements are satisfied.
Implant Placement and Loading Protocols — ITI 2018 consensus
7.How does neutrophil responsiveness contribute to the host inflammatory burden?
The cardiovascular-periodontal consensus describes increased total and extracellular reactive oxygen species production by peripheral neutrophils from periodontitis patients. Both unstimulated hyperactivity and exaggerated responses to stimulation have been observed. Successful periodontal treatment reduces stimulated hyperreactivity, while unstimulated hyperactivity may persist. These findings distinguish the microbial stimulus from the host response that amplifies the inflammatory burden.
Apply it
After treatment, a research assay shows reduced bacterially stimulated oxidant production but persistent unstimulated activity. Interpret these as different components of neutrophil responsiveness.
Common pitfall: An improved stimulated response does not establish normalization of every immune function.
Periodontitis and cardiovascular diseases — Consensus report
8.How does a barrier membrane contribute to guided regeneration?
A barrier membrane helps organize periodontal wound healing by limiting access of rapidly migrating tissues and protecting a space in which regeneration may occur. Its role is biologically different from merely adding mineralized volume. Clinical selection must also consider defect configuration, wound stability, and evidence supporting the material and procedure. The EFP guideline supports appropriate regenerative approaches in selected intrabony defects; it does not imply that every barrier design or combination is interchangeable.
Apply it
For a residual intrabony defect, a resident selects a membrane solely because it is available. Refocus selection on the regenerative objective, the defect's ability to support a stable wound, and clinical evidence for the proposed approach.
Common pitfall: Avoid treating a membrane as a passive cover with guaranteed benefit. Barrier function requires an appropriate indication and a wound environment compatible with healing.
New attachment following surgical treatment of human periodontal disease · EFP Clinical Guideline — Step 3
B. Diagnosisnot stated
9.How do probing depth and clinical attachment level differ?
Probing depth measures from the gingival margin to the probed pocket base; clinical attachment level uses a fixed reference, usually the cementoenamel junction. With recession, attachment loss equals probing depth plus recession. When the gingival margin is coronal to the reference, subtract that coronal distance. The distinction matters because swelling or recession changes the margin position: a shallow pocket may coexist with substantial historical attachment loss, while an enlarged gingiva can create a deep measurement without equivalent loss.
Apply it
A facial site has a 3 mm probing depth and a gingival margin 4 mm apical to the cementoenamel junction. Record 7 mm of clinical attachment loss rather than interpreting the shallow pocket as evidence of intact support.
Common pitfall: Do not substitute probing depth for attachment level. Their reference points differ, so recession and gingival enlargement can produce misleading impressions of disease severity.
10.What establishes a periodontitis case, and how are stages I and II distinguished?
A periodontitis case has detectable interdental attachment loss at two nonadjacent teeth, or buccal/oral attachment loss of at least 3 mm with pocketing greater than 3 mm at two teeth, after excluding other causes. Exclusions include traumatic recession, cervical caries, a draining endodontic lesion, vertical root fracture, and certain distal second-molar defects associated with third molars. Stage I has greatest interdental attachment loss of 1–2 mm, radiographic bone loss below 15%, maximum probing depth at most 4 mm, and mostly horizontal loss. Stage II has attachment loss of 3–4 mm, coronal-third bone loss of 15–33%, maximum probing depth at most 5 mm, and mostly horizontal loss. Neither includes periodontitis-related tooth loss. Higher complexity can raise the stage.
Apply it
Two nonadjacent teeth have interdental attachment loss of 3 mm, 20% horizontal bone loss, and maximum pockets of 5 mm, without attributable tooth loss or higher complexity. After excluding alternative causes, classify stage II.
Common pitfall: A deep isolated tract beside a nonvital tooth or fractured root does not independently establish periodontitis. Confirm the case definition before applying staging thresholds.
Staging and grading of periodontitis: Framework and proposal of a new classification and case definition · Staging and Grading Periodontitis — American Academy of Periodontology
11.Which findings distinguish stage III from stage IV complexity?
Stage III can include deep pockets, vertical defects, and class II or III furcation involvement. Stage IV adds a level of functional or rehabilitative complexity, such as masticatory dysfunction, bite collapse, drifting or flaring, or secondary occlusal trauma with substantial mobility. Loss of five or more teeth because of periodontitis also supports stage IV severity. The key distinction is the added management burden; severe attachment loss alone does not automatically establish stage IV.
Apply it
Two patients have comparable severe attachment loss. One retains a functional dentition; the other has bite collapse, pathologic migration, and impaired chewing requiring complex rehabilitation. Recognize the second patient's additional stage IV complexity.
Common pitfall: Do not assign stage IV simply because any tooth is mobile or missing. Establish the specified complexity and whether tooth loss was caused by periodontitis.
Staging and Grading Periodontitis — American Academy of Periodontology
12.How does direct progression evidence determine grade?
Grading estimates progression and incorporates risk modifiers. When reliable longitudinal records exist, direct evidence is preferred: no attachment or radiographic bone loss over five years supports grade A, less than 2 mm supports grade B, and 2 mm or more supports grade C. Measurements must be sufficiently comparable to represent change. A patient's current stage describes accumulated severity and complexity; the grade addresses progression behavior and should not be inferred from stage alone.
Apply it
Comparable records demonstrate 2.5 mm of periodontal attachment loss over five years. Use that direct progression evidence to support grade C, even if the patient's current destruction is less extensive than another patient's.
Common pitfall: Avoid averaging progression into a different interval without justification or ignoring measurement comparability. Apparent change from inconsistent methods is weaker evidence than reliable longitudinal documentation.
Staging and Grading Periodontitis — American Academy of Periodontology
13.How do bone-loss-to-age ratio and risk modifiers affect grade?
When direct progression evidence is unavailable, the percentage of radiographic bone loss at the most affected tooth divided by age provides indirect evidence. Ratios below 0.25 support grade A, 0.25–1.0 grade B, and above 1.0 grade C. Smoking and diabetes can increase the assigned grade: at least ten cigarettes daily or HbA1c of at least 7% in a patient with diabetes supports grade C modification. These modifiers supplement the progression assessment.
Apply it
A 40-year-old patient has 30% bone loss and no longitudinal records, giving a ratio of 0.75. Although the indirect estimate supports grade B, reported smoking of 15 cigarettes daily supports modification to grade C.
Common pitfall: Do not divide millimeters of bone loss by age when applying the percentage-based ratio. A favorable ratio also does not cancel a qualifying risk modifier.
Staging and Grading Periodontitis — American Academy of Periodontology
14.What separates peri-implant health from mucositis?
Peri-implant health is characterized by absence of clinical signs of inflammation. Mucositis is characterized principally by bleeding on gentle probing, with possible erythema or swelling, without bone loss beyond initial remodeling. Health can exist around an implant with reduced support, so bone height alone does not define current inflammatory status. No single probing-depth range universally defines health; interpretation must include inflammation, tissue dimensions, and comparison with established baseline measurements.
Apply it
An implant has stable radiographic support and bleeding on gentle probing at several sites. Diagnose an inflammatory soft-tissue condition consistent with mucositis rather than calling the implant healthy solely because its bone level is unchanged.
Common pitfall: Avoid using a universal pocket-depth cutoff to define implant health. Bleeding, remodeling history, and baseline comparison provide essential context that a single depth cannot supply.
Peri-implant diseases and conditions — 2017 World Workshop consensus report
15.How is peri-implantitis identified without previous records?
Peri-implantitis combines inflammation with progressive supporting bone loss beyond initial remodeling. When previous examination data are unavailable, the World Workshop case definition uses bleeding and/or suppuration on gentle probing, probing depth of at least 6 mm, and bone level at least 3 mm apical to the most coronal intraosseous portion of the implant. These fallback criteria help classify a current presentation; they do not establish the timing or rate of past destruction.
Apply it
A patient presents without implant records. Examination finds suppuration, a 7 mm pocket, and bone 4 mm apical to the most coronal intraosseous implant portion. These combined findings meet the no-baseline case-definition criteria for peri-implantitis.
Common pitfall: Do not diagnose peri-implantitis from a deep pocket alone. The fallback definition requires inflammatory findings and the specified radiographic bone-level criterion as well.
Peri-implant diseases and conditions — 2017 World Workshop consensus report
16.Why are baseline implant probing and radiographs important?
Baseline probing and radiographic measurements after completion of the implant-supported prosthesis provide a reference for subsequent change. Implant designs, tissue dimensions, placement positions, and early remodeling can produce different initial measurements. Comparing follow-up findings with an appropriate baseline helps distinguish stable anatomy from increasing probing depth and progressive bone loss. Record inflammation alongside the structural measurements, because bone level and current soft-tissue inflammatory activity describe related but different aspects of implant condition.
Apply it
A restored implant has a 5 mm probing depth without bleeding. A baseline chart documents the same depth and stable bone. Use the longitudinal comparison rather than assuming that the present depth alone proves disease progression.
Common pitfall: Avoid treating the first available radiograph as proof of progression. A single image shows present support, whereas progression requires a suitable comparison or fallback criteria.
Peri-implant diseases and conditions — 2017 World Workshop consensus report
C. Etiology of Periodontal and Peri-implant Diseases and Conditionsnot stated
17.What did experimental gingivitis establish about plaque accumulation?
The experimental gingivitis study linked suspension of oral hygiene with plaque accumulation, changes in microbial composition, and development of gingival inflammation. Resumption of oral hygiene was followed by resolution. The temporal sequence and reversibility support a causal role for plaque in experimental gingivitis. The appropriate inference is specific: the experiment does not show that every gingivitis site inevitably progresses to periodontitis or that all individuals have identical susceptibility to destructive disease.
Apply it
A patient interprets bleeding as a reason to stop cleaning. Explain how controlled plaque accumulation produced gingivitis and how resumed hygiene reversed the inflammation, then teach an effective cleaning method appropriate to the patient's tissues.
Common pitfall: Do not convert evidence for reversible gingivitis into a claim of inevitable attachment loss. Gingival inflammation and destructive periodontitis are related but distinct outcomes.
Experimental gingivitis in man — Theilade and colleagues, 1966
18.Why must periodontal treatment address both biofilm and patient susceptibility?
Periodontal treatment targets the microbial challenge while also addressing factors that modify susceptibility and healing, particularly smoking and diabetes control. The EFP treatment framework includes behavior change and risk-factor control alongside professional instrumentation. Patients with similar plaque deposits may have different progression histories and treatment responses, so plaque quantity alone cannot explain prognosis. Link local infection control with modifiable patient factors instead of choosing one as the exclusive explanation for ongoing disease.
Apply it
Two patients receive comparable instrumentation, but one continues smoking and has poorly controlled diabetes. Explain why equivalent mechanical treatment does not remove the difference in patient susceptibility, and incorporate risk-factor management into the treatment plan.
Common pitfall: Avoid interpreting a systemic risk factor as a reason to abandon biofilm control. Risk modification complements local periodontal treatment rather than substituting for it.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline · Perio & Diabetes — Recommendations for the oral-healthcare team
19.Which patient factors raise concern for peri-implant disease?
A history of periodontitis, poor plaque control, and lack of regular supportive care are important peri-implant disease risk indicators. They identify patients who need careful prevention, treatment of periodontal disease, and sustained follow-up. These factors influence planning but do not prove that a particular implant will fail. Distinguish a population-level association from an individual diagnosis: current peri-implant disease still requires clinical and, when relevant, radiographic evidence at the implant.
Apply it
A patient with previously treated severe periodontitis seeks an implant but has stopped maintenance. Discuss the need to restore disease control and establish ongoing supportive care rather than presenting implant placement as an escape from periodontal susceptibility.
Common pitfall: Do not label every implant in a periodontitis patient diseased. Risk history supports prevention and surveillance, while diagnosis depends on findings at the implant.
Peri-implant diseases and conditions — 2017 World Workshop consensus report · Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
20.How can a restoration contribute to peri-implant inflammation?
A restoration can contribute to peri-implant inflammation by retaining plaque, preventing effective cleaning, or leaving residual cement in a difficult-to-access location. These local factors can sustain a microbial challenge even when the patient attempts daily hygiene. Assessment should therefore include restoration contour, access for cleaning, and possible cement remnants. The finding identifies a correctable contributor; it does not replace assessment of inflammatory signs, supporting bone, and broader patient-level susceptibility.
Apply it
One implant remains inflamed despite improved hygiene elsewhere. Its bulky crown prevents passage of an interdental aid. Investigate the restoration's contribution and arrange correction of access while treating the inflamed peri-implant tissues.
Common pitfall: Avoid blaming every inflamed implant solely on patient compliance. A prosthesis that blocks cleaning creates a local obstacle that instruction alone may not overcome.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline · Clinical Performance of Screw- versus Cement-Retained Implant-Supported Fixed Reconstructions — ITI consensus
D. Prognosisnot stated
21.Which findings inform tooth survival prognosis?
Tooth prognosis integrates support loss, probing findings, mobility, furcation involvement, and patient-level factors such as smoking. The longitudinal prognosis study illustrates that clinical parameters carry useful information but predict survival imperfectly, especially among teeth outside clearly favorable categories. A prognosis is therefore an estimate under stated treatment and maintenance conditions. Explain the factors driving concern and avoid presenting a descriptive category as certainty about the timing or inevitability of tooth loss.
Apply it
A molar has substantial attachment loss, furcation involvement, and mobility in a smoker. Discuss the combined adverse findings and the conditions required for retention, while acknowledging that the initial prognosis cannot determine the tooth's exact survival time.
Common pitfall: Do not use a single unfavorable feature as an automatic extraction rule. Prognostic accuracy is limited, and combined findings plus treatment context matter.
22.Why should prognosis be reassessed after initial therapy?
Initial prognosis is made before the clinician knows the full treatment response or the patient's sustained ability to control plaque and attend maintenance. Reevaluation adds information about residual inflammation, pocket reduction, and modifiable risks. Some adverse features remain, while others improve with treatment. Updating prognosis makes planning conditional on observed response rather than preserving an early label indefinitely. This is particularly useful when deciding whether further periodontal treatment can support a strategically useful tooth.
Apply it
A tooth initially judged uncertain shows reduced inflammation and improved pocket measurements after treatment, and the patient demonstrates effective daily cleaning. Reassess its retention prospects before finalizing an irreversible extraction-based restorative plan for that region.
Common pitfall: Avoid either permanently fixing the initial prognosis or declaring it favorable after one improved visit. Structural limitations and sustained maintenance behavior still require consideration.
Prognosis versus actual outcome. III. The effectiveness of clinical parameters in accurately predicting tooth survival · EFP Clinical Guideline — Step 2
23.How should implant prognosis incorporate site and patient factors?
Implant prognosis depends on more than whether an implant can be inserted. Site conditions affect placement and stability, while periodontal history, plaque control, restorative cleansability, and supportive care influence longer-term disease risk. Separate the prospect of initial integration from sustained biological and restorative success. A technically feasible implant may still carry substantial maintenance demands. Explain which risks can be modified and which uncertainties remain, rather than promising a predictable lifetime from successful placement alone.
Apply it
An edentulous site appears suitable for placement, but the patient has active periodontitis and unreliable follow-up. Describe technical feasibility separately from long-term prognosis, and address disease control and maintenance commitment before proceeding with definitive planning.
Common pitfall: Do not equate adequate local bone with a favorable overall prognosis. Patient susceptibility and the ability to maintain the final restoration remain important.
Implant Placement and Loading Protocols — ITI 2018 consensus · Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
24.How does prognosis support a retention-versus-replacement decision?
Prognosis informs a decision by estimating likely outcomes under realistic treatment and maintenance conditions. It should be considered alongside restorability, function, strategic value, treatment burden, and the patient's preferences. Imperfect prediction makes an automatic conversion from a prognosis label to extraction inappropriate. Conversely, uncertainty does not justify retaining a tooth regardless of burden. Present the reasonable alternatives, explain the factors favoring each, and distinguish the tooth's biological outlook from its role in the comprehensive plan.
Apply it
A patient asks whether an uncertain molar must be replaced by an implant. Compare a monitored retention plan with extraction and replacement, explaining expected maintenance, functional value, uncertainty, and the patient's priorities before selecting an approach.
Common pitfall: Avoid assuming replacement eliminates future biological risk. A prognosis estimate supports shared planning but does not guarantee either tooth survival or implant success.
Prognosis versus actual outcome. III. The effectiveness of clinical parameters in accurately predicting tooth survival · Types of Consent — American Dental Association
E. Treatment Planning and Patient Managementnot stated
25.How should periodontal treatment be sequenced?
The EFP stage I–III framework progresses from behavior change and risk-factor control to subgingival instrumentation, then reassessment and indicated additional treatment, followed by supportive care. Sequencing allows the response to earlier interventions to guide later decisions. It also avoids choosing surgery solely from pretreatment measurements when inflammation and deposits remain uncontrolled. Urgent or problem-focused needs may require attention, but comprehensive planning should still identify how local care fits into disease control and maintenance.
Apply it
A patient requests immediate surgery for deep pockets while plaque control is poor. Explain the sequence of initial risk and biofilm management, instrumentation, and reevaluation so that any later surgery addresses residual needs under better conditions.
Common pitfall: Do not interpret sequencing as a rigid calendar or automatic progression to surgery. Each subsequent intervention should respond to remaining disease and patient circumstances.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
26.What makes informed consent a meaningful clinical process?
Informed consent requires a discussion that helps the patient understand the proposed treatment, expected benefits, material risks, and reasonable alternatives, including the implications of declining treatment. The patient needs an opportunity to ask questions and make a voluntary choice. Documentation records that process; a signed form alone does not demonstrate understanding. Specific legal requirements vary by jurisdiction, so the professional communication principles should not be presented as a universal statutory formula.
Apply it
Before regenerative surgery, a patient signs a form but cannot explain why treatment is proposed or what alternatives exist. Pause to explain those points in understandable language, invite questions, and confirm a voluntary decision before proceeding.
Common pitfall: Avoid treating a signature as a substitute for conversation. A technically complete document does not establish that the patient understood the decision.
27.When is cardiac antibiotic prophylaxis relevant to periodontal procedures?
Under the AHA recommendations summarized by the ADA, prophylaxis is reserved for patients with specified cardiac conditions associated with the highest risk of adverse outcomes from infective endocarditis. It applies to qualifying dental procedures involving gingival manipulation, manipulation of the periapical region, or oral mucosal perforation. Both the cardiac condition and procedure must be assessed. A prosthetic cardiac valve is a qualifying example; the fact that a procedure may cause bleeding is insufficient by itself.
Apply it
A patient with a prosthetic cardiac valve is scheduled for subgingival instrumentation. Recognize the combination of a qualifying cardiac condition and gingival manipulation, then use the current recommended prophylaxis guidance rather than a routine antibiotic habit.
Common pitfall: Do not extend prophylaxis to every cardiovascular diagnosis or every dental visit. Eligibility depends on the specified cardiac risk category and planned procedure.
Antibiotic Prophylaxis Prior to Dental Procedures — American Dental Association
28.Why does a prosthetic joint alone usually not justify dental prophylaxis?
The ADA states that prophylactic antibiotics are generally not recommended solely to prevent prosthetic joint infection before dental procedures. A joint replacement therefore should not be treated as equivalent to a qualifying high-risk cardiac condition. For a patient with a history of complications associated with joint replacement, an individualized discussion with the patient and orthopedic surgeon may be appropriate. Keep the proposed indication explicit rather than using one blanket rule for unrelated implanted devices.
Apply it
A patient with an uncomplicated knee replacement requests antibiotics before routine periodontal maintenance. Explain the general recommendation against joint-based routine prophylaxis, review relevant complication history, and distinguish this issue from cardiac infective-endocarditis eligibility.
Common pitfall: Avoid assuming that any artificial implant creates the same prophylaxis indication. Prosthetic joints and high-risk cardiac conditions follow different evidence-based recommendations.
Antibiotic Prophylaxis Prior to Dental Procedures — American Dental Association
29.Which findings after local anesthetic injection suggest systemic toxicity?
Early toxicity cues include tinnitus, metallic taste, perioral tingling, incoherent speech, tremor, or altered consciousness after injection. Progression can involve seizures, respiratory depression, hypotension, and cardiovascular collapse. Stop further administration, initiate the emergency response, and prioritize oxygenation, a patent airway, and assisted ventilation when needed while assessing circulation. The labeling emphasizes continuous monitoring after injection and immediate access to resuscitative equipment and trained personnel.
Apply it
A patient develops tinnitus and twitching during incremental injection. Stop injection and assess breathing, circulation, and consciousness immediately rather than administering more anesthetic for presumed anxiety.
Common pitfall: Negative aspiration does not exclude intravascular injection, and toxicity from multiple local anesthetics is additive.
DailyMed - LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE injection, solution
30.Why must periodontal and medical diabetes care be coordinated?
Diabetes assessment affects periodontal risk evaluation, treatment planning, and follow-up. The oral healthcare team should establish the patient's diabetes history and available glycemic-control information and coordinate with medical care when control is uncertain or concerns arise. Periodontal treatment and improved home care remain important, while medication changes belong within the patient's medical management. Coordination makes the plan responsive to the patient's actual condition instead of relying on the diagnostic label alone.
Apply it
A patient reports diabetes but does not know recent glycemic results and has disengaged from medical follow-up. Explain the periodontal relevance, encourage medical review, and coordinate information needed for a treatment plan suited to the patient's condition.
Common pitfall: Avoid independently adjusting diabetes medication or assigning control from symptoms alone. Medical coordination complements periodontal care and should be based on relevant patient information.
Perio & Diabetes — Recommendations for the oral-healthcare team
F. Periodontal Therapy: Non-Surgical & Surgicalnot stated
31.What is the objective of subgingival instrumentation?
Subgingival instrumentation reduces the subgingival biofilm and deposits associated with periodontal inflammation. It follows patient-level plaque-control and risk-management efforts and is evaluated through clinical response rather than the sensation of root smoothness alone. The EFP framework accepts appropriate hand or powered instrumentation. Selection should support effective access and deposit removal while preserving tissues. Instrumentation is an active treatment step, but its long-term value depends on subsequent home care, reevaluation, and supportive periodontal care.
Apply it
After initial hygiene instruction, a patient undergoes subgingival instrumentation. At review, assess bleeding, probing depths, and residual treatment needs rather than declaring success solely because the roots felt smooth at the end of the appointment.
Common pitfall: Avoid equating aggressive removal of root substance with better debridement. The therapeutic target is the disease-associated biofilm and deposits, followed by measurable clinical improvement.
EFP Clinical Guideline — Step 2 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
32.How should response to nonsurgical therapy be evaluated?
Reevaluation determines whether initial therapy has controlled inflammation and reduced pocketing sufficiently or whether residual sites require additional treatment. Compare probing depths, bleeding, oral hygiene, and risk-factor control with the initial findings. In the EFP framework, important treatment targets include absence of pockets at least 5 mm deep that bleed on probing and absence of pockets at least 6 mm deep. Improvement alone is not equivalent to reaching these site-level endpoints.
Apply it
Following instrumentation, most sites improve but a molar retains a 6 mm pocket. Record the overall response and the residual site separately, then investigate anatomy and treatment options instead of classifying the entire case as completed.
Common pitfall: Do not let a lower full-mouth average hide a persistent deep site. Additional treatment decisions require site-specific findings and the patient's overall disease-control status.
EFP Clinical Guideline — Step 2 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
33.How does resective periodontal surgery differ from access surgery?
Access surgery exposes root surfaces for debridement. Resective surgery additionally changes hard- or soft-tissue architecture to reduce pocket depth. EFP suggests resective surgery for selected residual pockets at least 6 mm deep after adequate initial therapy, while weighing increased recession. This tradeoff matters when root exposure or esthetic change would be consequential.
Apply it
A residual deep posterior pocket lacks a suitable regenerative target. Compare resective pocket reduction with access surgery, including the expected recession burden.
Common pitfall: Pocket reduction through tissue resection does not demonstrate reconstruction of lost attachment.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
34.When should repeat instrumentation or access surgery be considered?
After appropriate initial treatment, inflamed residual 4–5 mm pockets may receive repeat subgingival instrumentation, particularly when deposits remain accessible. For residual pockets at least 6 mm deep, EFP supports considering access-flap surgery to improve treatment of inaccessible root surfaces. Defect morphology may favor regenerative or resective treatment instead. Surgery requires reassessment of plaque control and patient readiness. The decisive cue is persistent disease after adequate initial care, rather than an untreated deep measurement.
Apply it
A compliant patient retains a bleeding 7 mm posterior pocket after instrumentation. Evaluate the root and defect anatomy to choose an appropriate surgical approach rather than indefinitely repeating an intervention with limited access.
Common pitfall: Do not treat a 5 mm bleeding site with accessible deposits as equivalent to a persistent 7 mm site. Depth, inflammation, access, and prior response determine the next step.
EFP Clinical Guideline — Step 3 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
35.Which residual intrabony defects favor regenerative surgery?
The EFP guideline recommends regenerative surgery for suitable teeth with residual deep pockets associated with intrabony defects at least 3 mm deep. The intrabony component is the depth within the bony defect, not the entire probing depth. Patient plaque control, defect configuration, and the feasibility of wound stability influence the procedure. This indication distinguishes an opportunity to reconstruct lost support from a deep pocket whose anatomy does not offer the same regenerative target.
Apply it
After initial therapy, a tooth has a residual 7 mm pocket and a 4 mm intrabony component, with good plaque control. Discuss a regenerative approach based on the defect indication rather than selecting treatment from pocket depth alone.
Common pitfall: Do not confuse a 3 mm probing depth with a 3 mm intrabony defect. The recommendation concerns the bony component of an appropriate residual defect.
EFP Clinical Guideline — Step 3 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
36.Why are systemic antibiotics not routine adjuncts to instrumentation?
The EFP guideline advises against routine systemic antibiotics as an adjunct to subgingival instrumentation because potential benefits must be weighed against adverse effects and antimicrobial resistance. Selected patient categories may merit consideration after assessment, but deep pockets alone do not establish an indication. Mechanical biofilm disruption, patient plaque control, and risk management remain the foundation. Distinguish antibiotics used for a specific clinical indication from an automatic prescription attached to every periodontal treatment course.
Apply it
A generally healthy patient with periodontitis asks for antibiotics instead of completing instrumentation. Explain why systemic medication does not replace mechanical treatment and why routine adjunctive prescribing is inappropriate without a patient-specific reason.
Common pitfall: Avoid inferring an antibiotic indication solely from disease severity or patient preference. A potential adjunct requires a defensible indication and consideration of harms.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
37.How do chlorhexidine rinse and locally delivered chlorhexidine differ?
EFP recommendation R2.13 permits consideration of chlorhexidine mouth rinse for a limited period alongside mechanical debridement in selected cases. Staining is a relevant adverse effect. R2.14 separately permits consideration of locally administered sustained-release chlorhexidine as an adjunct to subgingival instrumentation; this delivers the agent locally rather than through rinsing. Both are Grade 0, open recommendations rather than routine requirements. The local-delivery evidence has high risk of bias and heterogeneity, with limited additional pocket-depth benefit and no established long-term benefit.
Apply it
A patient asks for indefinite rinsing instead of interdental cleaning. Explain the selected, limited-period rinse role and distinguish it from a sustained-release product placed at a treated site.
Common pitfall: Do not transfer a local-delivery result to mouth rinse or present either intervention as a replacement for mechanical treatment. Discuss staining when considering rinse use.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
38.Why is effective plaque control important before periodontal surgery?
Periodontal surgery is intended to improve treatment of residual disease in a patient who can sustain the result. Persistent inadequate plaque control maintains the inflammatory challenge and reduces the rationale for proceeding with elective periodontal surgery. The EFP guideline advises against surgery in patients who cannot achieve and maintain adequate self-performed oral hygiene. The decision should trigger renewed instruction, barrier assessment, and risk management rather than the assumption that surgery can compensate for uncontrolled daily biofilm.
Apply it
A patient has a surgically treatable residual defect but repeatedly demonstrates heavy plaque accumulation. Address practical cleaning barriers and establish improved control before elective surgery, explaining how daily behavior affects the value of the proposed intervention.
Common pitfall: Avoid presenting surgery as a substitute for patient plaque control. Better access created surgically still requires effective daily cleaning and supportive professional care.
Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
G. Implant-Related Therapynot stated
39.How do immediate, early, and late implant placement differ?
Placement timing describes the interval between extraction and implant insertion. Immediate placement occurs on the day of extraction. Early placement follows soft-tissue healing at 4–8 weeks or partial bone healing at 12–16 weeks. Late placement follows complete bone healing more than six months after extraction. These categories describe the site at surgery and remain separate from insertion-to-loading intervals. ITI emphasizes patient and site selection rather than assuming every socket supports an immediate protocol.
Apply it
An implant inserted six weeks after extraction is early placement after soft-tissue healing. Classify any later prosthetic loading separately using the interval from implant insertion.
Common pitfall: Do not infer immediate loading from immediate placement or use the extraction date to classify loading. The two timelines answer different clinical questions.
Implant Placement and Loading Protocols — ITI 2018 consensus
40.What does primary implant stability establish?
Primary stability describes mechanical fixation at placement. It is influenced by local bone and the implant–site relationship and informs whether a planned loading approach is appropriate. It is distinct from osseointegration, which develops biologically during healing. Measurements such as insertion torque or stability assessments contribute to a protocol-specific decision; no universal threshold should be assumed across every implant system and clinical setting. Adequate initial fixation does not prove completed biological integration or future disease resistance.
Apply it
An implant feels stable at insertion, and a trainee calls it fully osseointegrated. Clarify that the observation concerns immediate mechanical fixation and that biological integration and the decision to load require the intended protocol and healing context.
Common pitfall: Avoid treating a single stability reading as proof of long-term success. Mechanical fixation at insertion and biological integration represent different stages of implant treatment.
Implant Placement and Loading Protocols — ITI 2018 consensus
41.How does planned placement timing affect ridge-preservation decisions?
Waiting for complete healing permits ridge resorption and reduced bone volume. ITI recommends alveolar ridge preservation when patient or site factors require planned late placement. Thin facial walls or defects may instead lead to early placement with simultaneous augmentation. These findings connect the extraction plan to later site development and loading decisions.
Apply it
If placement must wait beyond six months, plan ridge preservation when arranging extraction.
Common pitfall: A delayed appointment does not preserve ridge dimensions by itself.
Implant Placement and Loading Protocols — ITI 2018 consensus
42.How should peri-implant mucositis be treated initially?
Initial mucositis management centers on effective patient-performed plaque control and professional mechanical plaque removal. Identify local obstacles, such as inaccessible prosthetic contours or residual cement, and address them where relevant. The aim is resolution of soft-tissue inflammation before supporting bone loss develops. Routine systemic antibiotics are not the foundation of this pathway. The 2023 EFP guideline also requires reevaluation, because performing debridement does not itself demonstrate that the inflammatory condition has resolved.
Apply it
An implant bleeds on probing but has no bone loss beyond remodeling. Provide professional mechanical cleaning, tailor home-care instruction, and correct an inaccessible contour, then arrange reassessment rather than prescribing antibiotics as the principal intervention.
Common pitfall: Avoid assuming mucositis is harmless because bone is stable. Its reversible soft-tissue stage is an opportunity for active treatment and renewed prevention.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
43.Why does peri-implantitis treatment begin with a nonsurgical phase?
The peri-implantitis care pathway begins by addressing patient plaque control, modifiable risk factors, prosthetic barriers, and professional mechanical treatment. This phase reduces the inflammatory challenge and tests whether the patient can maintain the implant before further intervention. Concomitant periodontitis also requires treatment. Reevaluation identifies persisting disease that may require surgical access or another strategy. Beginning nonsurgically does not imply that advanced peri-implantitis will predictably resolve without surgery; it establishes essential conditions for subsequent treatment and long-term supportive care.
Apply it
A patient with peri-implantitis has heavy plaque and a restoration that prevents cleaning. Correct those barriers and perform initial professional treatment before selecting further intervention, while explaining that additional surgery may still be necessary.
Common pitfall: Do not jump directly from radiographic bone loss to a surgical technique without addressing hygiene and access. Conversely, do not promise nonsurgical resolution of every lesion.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
44.Which peri-implantitis endpoints guide escalation and reconstructive selection?
Reevaluate the nonsurgical phase after 6–12 weeks. At implant level, EFP R7.3 endpoints are residual probing depths ≤5 mm, no suppuration, and at most one isolated bleeding spot; line or profuse bleeding is excluded even if confined to one site. Assess six sites with gentle probing. Unmet endpoints require consideration of additional treatment; surgery is recommended when indicated after adequate plaque control and correction of prosthetic barriers. For reconstructive selection, intraosseous defects at least 3 mm deep are preferred. This reconstructive suggestion rests on low-certainty evidence and requires assessment of defect configuration and implant maintainability.
Apply it
At eight weeks, an implant with all depths ≤5 mm, no suppuration, and one isolated bleeding spot meets the endpoints. Another with the same depths and no suppuration but profuse bleeding at one site fails the inflammatory endpoint. A cleanable implant retaining a suppurating 7 mm pocket and a 4 mm intraosseous defect requires assessment for further treatment, including surgery and possible reconstruction.
Common pitfall: Counting bleeding sites without recording bleeding character can misclassify persistent inflammation. A single line or profuse bleed fails the endpoint despite shallow residual pockets.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
H. Periodontal and Peri-implant Evaluation/Maintenancenot stated
45.How are supportive periodontal care intervals selected?
Supportive care intervals should reflect current periodontal status, risk profile, plaque control, and the patient's ability to sustain stability. The EFP guideline recommends individualized scheduling within a three- to twelve-month range after active periodontal therapy. Residual inflammation, smoking, poor control, or recurrent disease may support closer review. An interval is a clinical decision that can change over time, rather than a permanent entitlement determined solely by the date treatment ended.
Apply it
A treated patient has persistent bleeding, residual pockets, and inconsistent home care. Choose a shorter risk-based supportive interval and active management of those findings rather than assigning an annual visit simply because the active treatment course is complete.
Common pitfall: Do not apply the longest interval to every treated patient or assume all maintenance visits are identical. Risk and current findings should determine frequency and content.
EFP Clinical Guideline — Step 4 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
46.What findings support periodontal stability after treatment?
The EFP framework describes a stable treated periodontitis patient as having bleeding on probing below 10%, probing depths no greater than 4 mm, and no bleeding at 4 mm sites. Reduced support can remain despite clinical stability, because successful treatment does not erase past attachment loss. Stability is therefore a current condition assessed within a history of periodontitis. The patient still requires supportive care and reassessment of factors that could promote recurrent disease.
Apply it
A treated patient has 7% bleeding, all pockets at most 4 mm, and no bleeding at the 4 mm sites. Recognize the stability pattern while explaining why historical attachment loss and recurrence risk still justify supportive care.
Common pitfall: Do not call historical periodontitis cured because current inflammation is controlled. Stability on reduced support still requires ongoing prevention and periodic reassessment.
EFP Clinical Guideline — Step 4 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
47.How should recurrent periodontal disease be recognized during maintenance?
Maintenance should compare present findings with prior records, not simply remove deposits. New or increasing pocketing, persistent bleeding at residual sites, and evidence of additional attachment or bone loss require investigation and renewed treatment planning. Interpret changes alongside measurement consistency, plaque control, and patient risk. A maintenance appointment can therefore identify a need to return to active therapy. Repeating the same supportive procedure indefinitely is inappropriate when the evidence indicates ongoing disease.
Apply it
During supportive care, a previously shallow site now measures 6 mm and bleeds. Confirm the measurement, compare prior attachment and imaging records as indicated, and investigate the local cause before deciding on renewed active treatment.
Common pitfall: Avoid dismissing every change as measurement variation or assuming every bleeding site proves progression. Confirmed longitudinal findings and current inflammation must be interpreted together.
EFP Clinical Guideline — Step 4 · Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
48.When should mucositis be reassessed, and which findings require retreatment?
Reassess approximately two to three months after mucositis treatment. The implant-level endpoint is no suppuration and at most one nonprofuse bleeding point. Retreatment is indicated for at least two bleeding sites, any profuse bleeding site, or suppuration. Review cleaning effectiveness and remaining local barriers alongside these findings. An isolated nonprofuse bleeding point differs from multiple bleeding sites or profuse bleeding and should not automatically be interpreted as the same treatment failure.
Apply it
At review, an implant has one small bleeding spot and no suppuration, meeting the inflammatory endpoint. Another has profuse bleeding at one site and requires retreatment even though only one site bleeds.
Common pitfall: Do not use 'any bleeding' as the retreatment threshold or overlook profuse bleeding because it occurs at only one site.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
I. Oral Pathology and Oral Medicinenot stated
49.When does an oral lesion require prompt biopsy or referral, and can adjuncts change that decision?
An unexplained indurated ulcer or another clinically suspicious lesion warrants prompt biopsy by a trained clinician or immediate specialist referral. Absence of pain does not establish benignity. Light-based adjuncts and vital staining should not determine whether a mucosal abnormality needs biopsy; a reassuring result cannot resolve concerning examination findings. ADA guidance generally also discourages cytology for this purpose, while allowing a conditional cytology fallback when biopsy is not possible, advisable, or indicated. Persistence or progression despite negative cytology requires immediate biopsy or referral.
Apply it
An unexplained indurated ulcer remains concerning despite a reassuring optical examination. Arrange tissue assessment and provide its duration, site, appearance, palpation findings, and relevant history for clinicopathologic correlation.
Common pitfall: Do not substitute an adjunct for indicated tissue assessment. The conditional cytology fallback does not justify postponing an available biopsy of a suspicious lesion.
Oral Cancer Guideline — ADA, 2026 Update · ada_oral_cancer_guideline.pdf
50.How should incisional and excisional biopsy be selected?
Incisional biopsy samples representative tissue and is preferred when malignancy is in the differential, preserving subsequent definitive treatment planning. Select viable representative tissue rather than sampling only a necrotic ulcer center. Excisional biopsy removes the entire lesion and suits a lesion judged clearly benign, such as an irritation fibroma, when complete removal is appropriate. A punch is an instrument that can obtain an incisional sample or excise a small lesion; it does not itself define the diagnostic strategy. These distinctions follow the [AAOMS biopsy position paper](https://aaoms.org/wp-content/uploads/2024/03/oral_lesion_position_paper.pdf).
Apply it
For a large indurated ulcer concerning for carcinoma, arrange representative incisional sampling or specialist referral. For a small clinically benign irritation fibroma, excisional biopsy can provide both removal and histologic diagnosis.
Common pitfall: Lesion size alone does not justify excision when malignancy is suspected. Avoid crush injury and necrotic-only samples that compromise interpretation.
2027_ABP_QE_Blueprint.pdf · Oral Cancer Guideline — ADA, 2026 Update
51.How should a seemingly innocuous lesion be followed?
Document the initial assessment, address an identified local cause, and arrange reassessment in 10–14 days. ADA recommends biopsy or referral when an oral mucosal abnormality remains unresolved beyond 10–14 days after initial evaluation without a definitive diagnosis or treatment plan. Persistence or progression changes the diagnostic decision. This review pathway does not justify waiting when the lesion is already suspicious; that presentation warrants prompt biopsy or referral.
Apply it
An apparently traumatic lesion remains after removal of the suspected irritant and a 14-day review, with no definitive diagnosis. Recommend biopsy or referral rather than repeatedly attributing persistence to trauma.
Common pitfall: Do not turn a provisional benign impression into indefinite observation. The 10–14-day review also does not postpone assessment of an already suspicious lesion.
52.How can a denture-associated ulcer be differentiated from carcinoma and a reactive ulcerative mimic?
Consider traumatic ulcer, oral squamous cell carcinoma, and traumatic ulcerative granuloma with stromal eosinophilia (TUGSE). Contact with an injuring flange and healing after correction support trauma. Persistent ulceration, induration, or raised margins require tissue assessment; trauma history does not exclude carcinoma. TUGSE can also produce an indurated ulcer, so palpation establishes concern rather than a definitive diagnosis. Representative incisional biopsy permits histologic discrimination. An eosinophil-rich inflammatory infiltrate with reactive stromal proliferation can support TUGSE after clinicopathologic correlation, as illustrated in an [original TUGSE report](https://pmc.ncbi.nlm.nih.gov/articles/PMC11003278/).
Apply it
A denture-associated ulcer persists after denture withdrawal. Biopsy showing invasive poorly differentiated squamous cell carcinoma changes the conclusion from presumed trauma to malignancy and requires specialist cancer management. This diagnostic reversal occurred in an [original clinical report](https://pubmed.ncbi.nlm.nih.gov/26581660/). A reactive eosinophil-rich specimen instead supports a different pathway after clinical correlation.
Common pitfall: Neither an identifiable irritant nor induration settles the diagnosis. A nonspecific or unrepresentative biopsy must not override a persistently suspicious examination.
J. Implant Restorationsnot stated
53.How are implant loading and immediate restoration defined?
ITI defines immediate loading as connection of an occluding prosthesis within one week of implant placement. Immediate restoration occurs within one week but is kept out of occlusion. Early loading occurs between one week and two months, and conventional loading follows a healing period longer than two months. These categories classify insertion-to-loading timing and occlusal conditions, separately from extraction-to-placement timing. An out-of-occlusion provisional can still transmit mechanical forces and requires appropriate case selection.
Apply it
An implant in a healed ridge receives an occluding restoration six weeks later: early loading. A crown connected two days after insertion and held out of occlusion is immediate restoration.
Common pitfall: Do not classify loading from the extraction date or assume that removing occlusal contacts makes an implant-supported provisional mechanically unloaded.
Implant Placement and Loading Protocols — ITI 2018 consensus
54.How do restorative material and retention method interact in complication assessment?
The 2013 ITI consensus reported higher failure for cemented all-ceramic than cemented metal-ceramic prostheses in the reviewed literature; that difference was not found for screw-retained prostheses. Screw retention showed more ceramic chipping than cement retention. Distinguish chipping as a technical complication from prosthesis failure, and interpret material results within the retention method and designs studied.
Apply it
A patient equates any ceramic chip with complete restoration failure. Explain the distinction and assess the affected reconstruction.
Common pitfall: These historical pooled findings do not rank every contemporary ceramic or establish that one retention method prevents complications.
55.How should screw and cement retention be compared?
Screw- and cement-retained implant reconstructions have different technical and biological tradeoffs, and the ITI consensus does not establish a universal preference for all situations. Screw retention supports retrieval and avoids a cement margin, while cement retention introduces the need to control and remove excess cement. Screw access position and restorative design also matter. Choose a retention strategy for the clinical configuration and expected maintenance needs rather than treating either approach as universally complication-free.
Apply it
A case requires easy retrieval, and excess cement removal would be difficult because of a deep margin. Include those factors when considering screw retention, while checking whether the planned access position and restoration design are acceptable.
Common pitfall: Avoid claiming that one retention method prevents every biological or technical complication. Case design and maintenance remain important whichever retention strategy is selected.
56.Why must definitive implant restorations remain cleanable?
A definitive implant restoration must permit effective patient cleaning and professional assessment, because a design that obstructs access can sustain plaque-associated inflammation. Esthetic appearance alone is an incomplete measure of success. Evaluate contours, interdental access, and the ability to inspect and maintain the peri-implant tissues before accepting the final prosthesis. When inflammation persists, assess whether the restoration itself needs modification rather than repeatedly increasing hygiene instruction that the anatomy makes impossible to follow.
Apply it
A final bridge looks acceptable but prevents the patient from passing the prescribed cleaning aid around two implants. Reassess the restorative design and achievable hygiene access before accepting it as a satisfactory definitive result.
Common pitfall: Do not assume a highly polished surface compensates for inaccessible contours. A smooth restoration can still prevent effective daily cleaning and professional maintenance.
Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
K. Periodontal and Systemic Relationshipsnot stated
57.How does diabetes control influence periodontal risk assessment?
Diabetes and periodontal disease have a clinically important bidirectional relationship. Poorer glycemic control is associated with greater periodontal risk and can affect the expected course of disease and treatment. Assessment should therefore include relevant diabetes history and available glycemic-control information, rather than treating all patients with diabetes as equivalent. Incorporate that information into risk communication, treatment planning, and follow-up while continuing direct management of the periodontal microbial challenge and local disease findings.
Apply it
Two patients have diabetes and similar periodontal measurements, but one has substantially poorer glycemic control. Explain why their risk assessments and coordination needs may differ even though the diabetes diagnosis and current pocket depths appear similar.
Common pitfall: Avoid assuming that diabetes automatically predicts the same periodontal outcome in every patient. Glycemic control, local disease, behavior, and treatment response still matter.
Perio & Diabetes — Recommendations for the oral-healthcare team
58.What can be said about periodontal treatment and glycemic control?
Periodontal treatment can contribute to improved glycemic control in people with diabetes and periodontitis, supporting integration of oral and medical care. The appropriate claim is an additional potential benefit of treating periodontal inflammation, not a guaranteed individual response or a replacement for diabetes medication and lifestyle management. Discuss the relationship without promising a specific HbA1c reduction for a particular patient. Continue evaluating periodontal outcomes directly rather than judging periodontal treatment solely by a laboratory change.
Apply it
A patient hopes periodontal treatment will allow immediate discontinuation of diabetes medication. Explain the potential glycemic benefit while making clear that medication decisions remain part of medical management and that periodontal success also requires local clinical assessment.
Common pitfall: Do not promise a fixed glycemic improvement or recommend stopping diabetes treatment. A group-level benefit does not determine an individual patient's medication needs.
Perio & Diabetes — Recommendations for the oral-healthcare team
59.What does the periodontitis–cardiovascular association establish?
The cardiovascular consensus recognizes an association between periodontitis and cardiovascular disease. Such evidence supports attention to shared risk factors and appropriate health advice, but association alone does not demonstrate that periodontitis caused an individual's cardiovascular condition. Shared exposures and other confounding factors must be considered. When counseling, distinguish epidemiologic association from intervention evidence showing that treating one condition changes the occurrence of clinically important outcomes in the other.
Apply it
A patient asks whether periodontitis caused a recent myocardial infarction. Explain the recognized association and shared risk context, encourage appropriate cardiovascular care, and avoid assigning individual causation from the coexistence of the two diagnoses.
Common pitfall: Do not convert a population association into certainty about an individual's cause of disease. Biological plausibility and co-occurrence do not settle causal attribution.
Periodontitis and cardiovascular diseases — Consensus report
60.Why do improved cardiovascular markers not prove event prevention?
Periodontal treatment can improve some inflammatory or vascular surrogate measures, but a surrogate is not the same outcome as myocardial infarction, stroke, or cardiovascular death. The cardiovascular consensus does not establish that periodontal treatment prevents these clinical events. This distinction matters when explaining benefits: periodontal therapy is justified for oral health, and possible systemic marker improvements should be described at their actual evidentiary level. Do not substitute an intermediate measurement for a proven patient-important outcome.
Apply it
A study reports improved endothelial function after periodontal therapy. Explain that the result supports a vascular surrogate effect, while a claim of fewer myocardial infarctions would require evidence measuring those clinical events directly.
Common pitfall: Avoid presenting a favorable biomarker as proof of cardiovascular protection. The mechanism may be plausible while the effect on actual clinical events remains unestablished.
Periodontitis and cardiovascular diseases — Consensus report
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Use the official 2027 domains A–K as the full study map; no official percentage weights are published.
- Separate severity, complexity, progression, and risk modifiers when assigning periodontal stage and grade.
- Interpret periodontal and implant measurements against appropriate reference points and longitudinal records.
- Connect initial therapy, reevaluation, residual defect anatomy, and patient plaque control to additional treatment decisions.
- Distinguish implant placement timing, primary stability, restoration timing, and functional loading.
- Apply representative mechanisms and clinical tradeoffs in socket anatomy, neutrophil activity, anesthetic toxicity, resective surgery, ridge preservation, and restorative materials.
- Practise prognosis and consent as conditional decisions that integrate patient priorities and maintenance demands.
- Match clinical claims to their evidence: attachment gain versus histologic regeneration, association versus causation, and surrogate change versus clinical events.
A practical preparation plan
1. Map the complete 2027 outline
Create a study record for every official objective. Use these selected lessons as examples, then extend study to the remaining objectives in surgical anatomy, immune pathways, emergencies, mucogingival procedures, sinus development, lesion histology, and material science using the Board's recommended professional literature.
2. Build diagnostic calculations
Practise attachment-level calculations, the periodontitis case definition, severity and complexity staging, five-year progression thresholds, and bone-loss-to-age ratios. State the evidence supporting each classification and identify which modifiers can change the result.
3. Work through treatment branches
For each case, identify initial disease-control needs, reevaluation findings, residual pocket or defect anatomy, and the next justified intervention. Compare repeat instrumentation, access, resective, and regenerative approaches while keeping periodontal and peri-implant endpoints distinct.
4. Compare implant protocols precisely
Describe extraction-to-placement timing separately from insertion-to-loading timing. Add socket-wall findings, primary stability, augmentation needs, occlusal status, prosthetic access, and a contingency when immediate treatment conditions are not achieved.
5. Explain every alternative
Complete the independent questions, then justify why each alternative is less appropriate using the actual option text. Use the flashcards to recall mechanisms and criteria rather than memorizing answer positions.
6. Audit maintenance and evidence claims
Revisit cases after treatment: determine stability, residual disease, supportive intervals, and recurrence management. Apply mucositis retreatment thresholds and oral-lesion review timing. Check that every claimed systemic or regenerative benefit matches the outcome actually measured.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- Qualifying Examination — American Board of Periodontology
- Policies & Resources — American Board of Periodontology
- Qualifying Exam 2027 — Domain/Objective
- Candidate's Guide to Board Certification — Qualifying Exam
- Xylocaine Dental — prescribing information
- New attachment following surgical treatment of human periodontal disease
- Relative risk — NCI Dictionary of Cancer Terms
- Staging and Grading Periodontitis — American Academy of Periodontology
- Staging and grading of periodontitis: Framework and proposal of a new classification and case definition
- Peri-implant diseases and conditions — 2017 World Workshop consensus report
- Experimental gingivitis in man — Theilade and colleagues, 1966
- Prognosis versus actual outcome. III. The effectiveness of clinical parameters in accurately predicting tooth survival
- Types of Consent — American Dental Association
- Antibiotic Prophylaxis Prior to Dental Procedures — American Dental Association
- Treatment of stage I–III periodontitis — The EFP S3 level clinical practice guideline
- EFP Clinical Guideline — Step 2
- EFP Clinical Guideline — Step 3
- EFP Clinical Guideline — Step 4
- Implant Placement and Loading Protocols — ITI 2018 consensus
- Prevention and treatment of peri-implant diseases — The EFP S3 level clinical practice guideline
- Oral Cancer Guideline — ADA, 2026 Update
- Clinical Performance of Screw- versus Cement-Retained Implant-Supported Fixed Reconstructions — ITI consensus
- Perio & Diabetes — Recommendations for the oral-healthcare team
- Periodontitis and cardiovascular diseases — Consensus report
- 2027_ABP_QE_Blueprint.pdf
- DailyMed - LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE injection, solution
- ada_oral_cancer_guideline.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.